These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 21741988)
1. Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease. Patki G; Lau YS Pharmacol Biochem Behav; 2011 Oct; 99(4):704-11. PubMed ID: 21741988 [TBL] [Abstract][Full Text] [Related]
2. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. Thomas B; Mohanakumar KP J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127 [TBL] [Abstract][Full Text] [Related]
3. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases. López A; Ortiz F; Doerrier C; Venegas C; Fernández-Ortiz M; Aranda P; Díaz-Casado ME; Fernández-Gil B; Barriocanal-Casado E; Escames G; López LC; Acuña-Castroviejo D PLoS One; 2017; 12(8):e0183090. PubMed ID: 28800639 [TBL] [Abstract][Full Text] [Related]
5. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity. Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Antolín I; Mayo JC; Sainz RM; del Brío Mde L; Herrera F; Martín V; Rodríguez C Brain Res; 2002 Jul; 943(2):163-73. PubMed ID: 12101038 [TBL] [Abstract][Full Text] [Related]
7. Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. Zaitone SA; Hammad LN; Farag NE Pharmacol Rep; 2013; 65(5):1213-26. PubMed ID: 24399717 [TBL] [Abstract][Full Text] [Related]
8. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related]
9. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration. Pothakos K; Kurz MJ; Lau YS BMC Neurosci; 2009 Jan; 10():6. PubMed ID: 19154608 [TBL] [Abstract][Full Text] [Related]
10. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats. Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494 [TBL] [Abstract][Full Text] [Related]
13. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
14. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway. Morgan WW; Nelson JF Brain Res; 2001 Dec; 921(1-2):115-21. PubMed ID: 11720717 [TBL] [Abstract][Full Text] [Related]
15. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model. Gu PS; Moon M; Choi JG; Oh MS J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. Lau YS; Patki G; Das-Panja K; Le WD; Ahmad SO Eur J Neurosci; 2011 Apr; 33(7):1264-74. PubMed ID: 21375602 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease. Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554 [TBL] [Abstract][Full Text] [Related]
18. Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson's Disease via Peroxisome Proliferator-Activated Receptorα. Prorok T; Jana M; Patel D; Pahan K Neurochem Res; 2019 Apr; 44(4):751-762. PubMed ID: 30612307 [TBL] [Abstract][Full Text] [Related]
19. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. Yokoyama H; Takagi S; Watanabe Y; Kato H; Araki T J Neural Transm (Vienna); 2008 Jun; 115(6):831-42. PubMed ID: 18235988 [TBL] [Abstract][Full Text] [Related]
20. Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF. Patel D; Jana A; Roy A; Pahan K J Neuroimmune Pharmacol; 2019 Sep; 14(3):503-518. PubMed ID: 31119595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]